About
Camp4Tx develops antisense oligonucleotide (ASO) therapeutics designed to selectively upregulate gene expression to treat diseases caused by insufficient protein expression.
Explore Camp4Tx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.